Calidi Biotherapeutics In...
(CLDI)
undefined
undefined%
At close: undefined
1.29
1.67%
Pre-market Jan 07, 2025, 05:00 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -29.22M | -25.43M | 3.39M | -7.94M |
| Depreciation & Amortization | 1.26M | 260.00K | 153.00K | 117.00K |
| Stock-Based Compensation | 4.81M | 6.14M | 1.33M | 968.00K |
| Other Working Capital | -72.00K | 1.95M | -354.71K | 652.00K |
| Other Non-Cash Items | 2.41M | 7.28M | -4.24M | 77.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a |
| Change in Working Capital | -6.24M | 3.57M | -290.87K | 945.00K |
| Operating Cash Flow | -26.98M | -13.21M | -1.08M | -4.83M |
| Capital Expenditures | -585.00K | -428.00K | -206.00K | -351.00K |
| Acquisitions | 9.00K | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -230.00M | n/a |
| Sales Maturities Of Investments | n/a | 190.01M | n/a | n/a |
| Other Investing Acitivies | 98.00K | -66.00K | -9.00K | -37.00K |
| Investing Cash Flow | -478.00K | -494.00K | -230.00M | -388.00K |
| Debt Repayment | 899.00K | 1.38M | n/a | 1.88M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 25.38M | 10.71M | 232.11M | -179.00K |
| Financial Cash Flow | 29.04M | 12.09M | 232.15M | 4.70M |
| Net Cash Flow | 1.58M | -590.65K | 642.65K | -514.00K |
| Free Cash Flow | -27.57M | -13.64M | -1.29M | -5.18M |